Hydrogel delivery of purinergic enzymes improves cardiac ischemia/reperfusion injury is a research paper published in Journal of Molecular and Cellular Cardiology (2023). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAMS NIH HHS
Grant: R01 AR062368
NIAMS NIH HHS
Grant: R01 AR062920
American Heart Association
Grant: 20PRE35080002
NHLBI NIH HHS
Grant: R01 HL140223
FWCI
3.99
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 5 of Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A2BR signaling
Additional file 2 of Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A2BR signaling
Additional file 3 of Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A2BR signaling
Additional file 1 of Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A2BR signaling
Additional file 4 of Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A2BR signaling
Additional file 5 of Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A2BR signaling
Additional file 3 of Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A2BR signaling
Additional file 1 of Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A2BR signaling
Additional file 4 of Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A2BR signaling
Additional file 2 of Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A2BR signaling